[{"arm_notes": "", "treatment_id": null, "treatment_name": "1:Middle-dose vaccine for subjects aged 18-55 years (0; 28 day regimen);2:Middle-dose vaccine for subjects aged > 55 years (0; 28 day regimen);3:Middle-dose vaccine for subjects aged 18 to 55 years (0; 28 day regimen);4:High-dose vaccine for subjects aged > 55 years (0; 28 day regimen);5:High-dose vaccine for subjects aged 18-55 years (0; 14; 28 day regimen);6:High-dose vaccine for subjects aged >55 years (0; 14; 28 day regimen);7:Placebo(0.5mL)for subjects aged 18-55 years (0; 28 day regimen);8:Placebo(0.5mL) for subjects aged > 55 years (0; 28 day regimen);9:Placebo (1ml) for subjects aged 18-55 years (0; 14; 28 day regimen);10:Placebo (1ml) for subjects aged > 55 years (0; 14; 28 day regimen);11:Placebo (1ml) for subjects aged 18-55 years (0; 28 day regimen);12:Placebo (1ml) for subjects aged > 55 years (0; 28 day regimen);", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "1:Middle-dose vaccine for subjects aged 18-55 years (0; 28 day regimen)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "2:Middle-dose vaccine for subjects aged > 55 years (0; 28 day regimen)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "3:Middle-dose vaccine for subjects aged 18 to 55 years (0; 28 day regimen)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "4:High-dose vaccine for subjects aged > 55 years (0; 28 day regimen)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "5:High-dose vaccine for subjects aged 18-55 years (0; 14; 28 day regimen)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "6:High-dose vaccine for subjects aged >55 years (0; 14; 28 day regimen)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "7:Placebo(0.5mL)for subjects aged 18-55 years (0; 28 day regimen)", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "8:Placebo(0.5mL) for subjects aged > 55 years (0; 28 day regimen)", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "9:Placebo (1ml) for subjects aged 18-55 years (0; 14; 28 day regimen)", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "10:Placebo (1ml) for subjects aged > 55 years (0; 14; 28 day regimen)", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "11:Placebo (1ml) for subjects aged 18-55 years (0; 28 day regimen)", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "12:Placebo (1ml) for subjects aged > 55 years (0; 28 day regimen);", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "Middle-dose;2 (0,28 day regimen);18-55 years", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Middle-dose;2 (0,28 day regimen);> 55 years", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "High-dose;2 (0, 28 day regimen); 18-55 years", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "High-dose;2 (0, 28 day regimen); > 55 years", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "High-dose;3 (0,14, 28 day regimen); 18-55 years", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "High-dose;3 (0,14, 28 day regimen); > 55 years", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]